Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Natera, Inc. (NTRA) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics & Research Average | - - | - - | - - | 67,938.17 | 2,018.90 | 256.76 | 9,150.24 | 261.33 | 0.00 | 91.6047 | 1.50 | 0.3951 | 0.0282 | 0.01 | -0.06 | 1.2737 | - - | ||
| Maximum | - - | - - | - - | 916,755.00 | 10,345.00 | 1,328.00 | 48,542.00 | 1,448.00 | 0.01 | 1,386.2094 | 8.28 | 0.6487 | 0.2444 | 0.07 | 0.15 | 2.6565 | - - | ||
| Minimum | - - | - - | - - | 30.00 | 19.00 | -29.00 | -648.00 | -163.00 | 0.00 | -299.9607 | -1.63 | -0.0242 | -0.5241 | -0.07 | -1.12 | 0.5844 | - - | ||
| Qiagen N.V. QGEN | 42.28 | 0.19 0.45% | 403 vs. 1,218 | 9,379.00 | 458.00 | 80.00 | 94.00 | 2,486.00 | 0.3600 | 29.2114 | 0.0000 | 0.6283 | 0.1758 | 0.0224 | 0.0139 | 1.2067 | 221.00 | ||
| Neogen Corporation NEOG | 14.90 | 0.01 0.03% | 566 vs. 1,507 | 3,229.00 | 228.00 | -2.00 | -62.00 | 561.00 | -0.0093 | -460.3506 | 0.0000 | 0.5108 | -0.0088 | -0.0006 | -0.0004 | 2.1669 | 216.00 | ||
| NeoGenomics, Inc. NEO | 15.24 | -0.12 -0.75% | 146 vs. 739 | 1,956.00 | 156.00 | -27.00 | -31.00 | -274.00 | -0.2100 | -17.9303 | 0.0000 | 0.3969 | -0.1732 | -0.0293 | -0.0165 | 6.8693 | 128.00 | ||
| Illumina, Inc. ILMN | 135.29 | 3.61 2.74% | 767 vs. 1,805 | 21,456.00 | 1,076.00 | -126.00 | 41.00 | -145.00 | -0.7900 | -41.8700 | 0.0000 | 0.6199 | -0.1171 | -0.0220 | -0.0125 | 1.1974 | 158.00 | ||
| Exact Sciences Corporation EXAS | 53.99 | 1.29 2.45% | 924 vs. 2,606 | 9,992.00 | 637.00 | -110.00 | -119.00 | -3,579.00 | -0.6000 | -29.1198 | 0.0000 | 0.7332 | -0.1729 | -0.0352 | -0.0173 | 1.3030 | 185.00 | ||
| Guardant Health, Inc. GH | 30.51 | -0.17 -0.55% | 615 vs. 2,113 | 3,769.00 | 168.00 | -114.00 | -37.00 | -2,256.00 | -0.9400 | -5.3587 | 0.0000 | 0.6125 | -0.6824 | -1.6839 | -0.0675 | 5.5171 | 123.00 | ||
| Natera, Inc. NTRA | 170.51 | 2.64 1.57% | 573 vs. 1,223 | 22,511.00 | 367.00 | -67.00 | 6.00 | -2,445.00 | -0.5600 | -41.5349 | 0.0000 | 0.5672 | -0.1838 | -0.0851 | -0.0460 | 3.8297 | 132.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.